Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

708 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Clinical usefulness of ondansetron hydrochloride for nausea and vomiting during repeated courses of chemotherapy for malignant lymphoma--impact of prognosis announcement on anti-emetic effect and evaluation of patient perception of chemotherapy-associated adverse events].
Kodama F, Mohri H, Motomura S, Fukawa H, Tanabe J, Koharasawa H, Kanamori H, Hashimoto Y, Harano H, Sakai R, Tomita N, Fujimaki K, Takemura S, Hattori M. Kodama F, et al. Among authors: takemura s. Gan To Kagaku Ryoho. 2002 Feb;29(2):273-9. Gan To Kagaku Ryoho. 2002. PMID: 11865634 Clinical Trial. Japanese.
Phase II study of CHOP-GR therapy for advanced-stage follicular lymphoma.
Tomita N, Kodama F, Oshima R, Hashimoto C, Koharazawa H, Takemura S, Yamazaki E, Fujimaki K, Sakai R, Fujita H, Fujisawa S, Kanamori H, Motomura S, Ishigatsubo Y. Tomita N, et al. Among authors: takemura s. Leuk Lymphoma. 2006 Jun;47(6):1041-7. doi: 10.1080/10428190500472784. Leuk Lymphoma. 2006. PMID: 16840195 Clinical Trial.
Evaluation of soluble interleukin-2 receptor and serum lactate dehydrogenase in malignant lymphoma.
Tomita N, Taguri M, Hashimoto C, Takasaki H, Fujimaki K, Motomura S, Koharazawa H, Takemura S, Fujita H, Yamazaki E, Kawasaki R, Taguchi J, Sakai R, Fujisawa S, Hattori Y, Kanamori H, Yamamoto W, Harano H, Ogawa K, Ishigatsubo Y. Tomita N, et al. Among authors: takemura s. Ann Hematol. 2015 Nov;94(11):1935-7. doi: 10.1007/s00277-015-2448-2. Epub 2015 Jul 25. Ann Hematol. 2015. PMID: 26208667 No abstract available.
The SIL index is a simple and objective prognostic indicator in diffuse large B-cell lymphoma.
Tomita N, Suzuki T, Miyashita K, Yamamoto W, Motohashi K, Tachibana T, Takasaki H, Kawasaki R, Hagihara M, Hashimoto C, Takemura S, Koharazawa H, Yamazaki E, Taguchi J, Fujimaki K, Fujita H, Sakai R, Fujisawa S, Motomura S, Kawamoto K, Sone H, Takizawa J. Tomita N, et al. Among authors: takemura s. Leuk Lymphoma. 2016 Dec;57(12):2763-2770. doi: 10.1080/10428194.2016.1195498. Epub 2016 Jun 20. Leuk Lymphoma. 2016. PMID: 27320054
[ABVD chemotherapy for Hodgkin lymphoma at a single institute].
Ohshima R, Motomura S, Hashimoto C, Miyazaki T, Ito S, Takasaki H, Hyo R, Koharazawa H, Takemura S, Yamazaki E, Fujimaki K, Tomita N, Fujita H, Fujisawa S, Harano H, Kanamori H, Ishigatsubo Y. Ohshima R, et al. Among authors: takemura s. Rinsho Ketsueki. 2010 Dec;51(12):1756-61. Rinsho Ketsueki. 2010. PMID: 21258185 Japanese.
Long-term outcome of L86 and L97 protocols for adult acute lymphoblastic leukemia.
Koharazawa H, Kanamori H, Sakai R, Hashimoto C, Takemura S, Hattori M, Taguchi J, Fujimaki K, Tomita N, Fujita H, Fujisawa S, Harano H, Ogawa K, Motomura S, Maruta A, Ishigatsubo Y. Koharazawa H, et al. Among authors: takemura s. Leuk Lymphoma. 2008 Nov;49(11):2133-40. doi: 10.1080/10428190802464711. Leuk Lymphoma. 2008. PMID: 19021056 Clinical Trial.
Phase II study of CHOP-GR therapy in diffuse large B-cell lymphoma.
Takemura S, Tomita N, Koharazawa H, Fujimaki K, Harano H, Hyo R, Yamazaki E, Hashimoto C, Miyazaki T, Ishigatsubo Y. Takemura S, et al. Int J Hematol. 2012 Aug;96(2):241-6. doi: 10.1007/s12185-012-1119-5. Epub 2012 Jun 10. Int J Hematol. 2012. PMID: 22684897 Clinical Trial.
708 results